Abstract Patterns of cell death have been divided into apoptosis, which is actively executed by specific proteases, the caspases, and accidental necrosis. However, there is now accumulating evidence indicating that cell death can occur in a programmed fashion but in complete absence and independent of caspase activation. Alternative models of programmed cell death (PCD) have therefore been proposed, including autophagy, paraptosis, mitotic catastrophe, and the descriptive model of apoptosis-like and necrosis-like PCD. Caspase-independent cell death pathways are important safeguard mechanisms to protect the organism against unwanted and potential harmful cells when caspase-mediated routes fail but can also be triggered in response to cytotoxic agents or other death stimuli. As in apoptosis, the mitochondrion can play a key role but also other organelles such as lysosomes and the endoplasmic reticulum have an important function in the release and activation of death factors such as cathepsins, calpains, and other proteases. Here we review the various models of PCD and their death pathways at molecular and organelle level and discuss the relevance of the growing knowledge of caspase-independent cell death pathways for cancer.
Balance between cell division and cell death is of utmost importance for the development and maintenance of multicellular organisms. Disorders of either process have pathologic consequences and can lead to disturbed embryogenesis, neurodegenerative diseases, or the development of cancer. Therefore, the equilibrium between life and death is tightly controlled and faulty elements can effectively be eliminated by a process called ''programmed cell death'' (PCD; ref. 1). In the past decades, PCD was held synonymous with apoptosis, a death process characterized by morphologic changes such as shrinkage of the cell, condensation of chromatin, and disintegration of the cell into small fragments (so-called ''apoptotic bodies'') that can be removed by phagocytosis (2) . The apoptotic cascade can be initiated via two major pathways, involving either the release of cytochrome c from the mitochondria (mitochondria pathway), or activation of death receptors in response to ligand binding (death receptor pathway; ref. 3, 4) . Upon triggering of either pathway, a specific family of cysteine proteases, the caspases, is activated to execute the cell's fate in a programmed fashion, leading to the typical morphologic changes (5) . Whereas apoptosis is an inherent, controlled cellular death program, the conceptual counterpart, necrosis, is a more chaotic way of dying, which results from circumstances outside the cell, and is characterized by cellular edema and disruption of the plasma membrane, leading to release of the cellular components and inflammatory tissue response (2, 6) .
In recent years, it has become evident that the classic dichotomy of apoptosis versus necrosis is a simplification of the highly sophisticated processes which guard the organism against unwanted and potentially harmful cells. Although caspases may be indispensable for the typical apoptotic morphology, the process of caspase activation is not the sole determinant of life and death decisions in PCD (7 -11) . One of the first clear demonstrations of caspase-independent PCD was given by Xiang et al., who showed that inhibition of caspase activities in the human leukemic cell line Jurkat did not inhibit Bax-induced cell death itself but only changed the apoptotic morphology of the dying cells (12) . Indeed, more evidence is now accumulating that PCD can occur in complete absence of caspases, and other, noncaspase proteases have been described to be able to execute PCD (13 -19) . In addition, Cauwels et al. have shown that caspase inhibition did not alleviate but rather exacerbated tumor necrosis factor (TNF)-a -induced toxicity in mice, indicating that caspaseindependent PCD is not restricted to in vitro models (20, 21) . The various forms of caspase-independent cell death cannot readily be classified as ''apoptosis'' or ''necrosis,'' and alternative types of PCD have been described (7, 8, 10, 13, 22 -24) . They do not occur only under physiologic circumstances but can also be induced by for instance TNF-a or chemotherapeutic drugs (25) . In this review, we focus on the various types of PCD and their death pathways at molecular and organelle level and discuss several stimuli that can lead to caspase-independent cell death.
Classification of Programmed Cell Death
The various types of PCD have in common that they are executed by active cellular processes that can be intercepted by interfering with intracellular signaling. This distinguishes them from accidental necrosis (22). Because it has become clear that inhibition of caspase activation does not necessarily protect against cell death stimuli but rather can reveal or even enhance underlying caspase-independent death programs, several models have been proposed (Fig. 1) .
One model involves autophagy, which is also called type II cell death to distinguish it from apoptosis or type I cell death (23, 26). This process is characterized by sequestration of bulk cytoplasm and organelles in double or multimembrane autophagic vesicles and their delivery to and subsequent degradation by the cell's own lysosomal system (autophagia is self-digestion in Greek). It serves to eliminate long-lived proteins and organelle components and has an important function in cellular remodeling due to differentiation, stress, or damage induced by cytokines. Cells that undergo excessive autophagy are triggered to die in a nonapoptotic manner, without activation of caspases (reviewed in ref. 27). Interestingly, autophagy may factor into both the promotion and prevention of cancer, and its role may be altered during tumor progression (reviewed in ref. 28). The autophagic capacity observed during experimental animal carcinogenesis has been shown decreased, indicating that breakdown of the autophagy process may contribute to the development of cancer (29 -31). This is supported by recent reports on the autophagy gene Beclin 1, which show that heterogeneous disruption of this gene leads to increased tumorigenesis in mice (32, 33). However, cancer cells may need autophagy to survive nutrient-limiting and low-oxygen conditions and autophagy may protect cancer cells against ionizing radiation by removing damaged elements (34, 35). The precise role of cell death by autophagy in mammals is, therefore, not yet fully understood (36).
Paraptosis has recently been characterized by cytoplasmatic vacuolation that begins with progressive swelling of mitochondria and the endoplasmic reticulum (ER). It typically does not response to caspase inhibitors nor does it involve activation of caspases, the formation of apoptotic bodies, or other characteristics of apoptotic morphology (10). Paraptosis has been described to be mediated by mitogen-activated protein kinases (37) and can be triggered by the TNF receptor family member TAJ/TROY (38) and the insulin-like growth factor I receptor (37).
Interestingly, paraptosis but not apoptosis has been shown to be inhibited by AIP1/Alix, a protein interacting with the cell calciumbinding death-related protein ALG-2 (37), suggesting that this type of cell death is fundamentally different from apoptosis. There are, however, only a few reports on paraptosis, and they do not make a comparison with other types of PCD such as autophagy. It remains, therefore, to be established whether autophagy and paraptosis represent independent types of PCD.
Mitotic catastrophe is another cell death pathway, which is not typical for apoptosis. It is triggered by mitotic failure caused by defective cell cycle checkpoints and the (threatening) development of aneuploid cells that are doomed to die (reviewed in ref. 24). Mitotic catastrophe can, in particular, be triggered by microtubule stabilizing or destabilizing agents and DNA damage (39). This death pathway kills the cell during or close to the metaphase in a p53-independent manner, or occurs partially dependent of p53 after failed mitosis by activation of a polyploidy checkpoint. Mitotic catastrophe has been reported to be accompanied by mitochondrial membrane permeabilization and caspase activation (40), but others have argued that it is fundamentally different from apoptosis, as caspase inhibition or Bcl-2 overexpression fails to prevent catastrophic mitosis or the development of giant multinucleated cells (39, 41). Whether mitotic catastrophe represents a fully caspase-independent type of PCD is therefore still a matter of debate.
In contrast to the more specific definitions of PCD above, Leist and Jäättelä proposed a descriptive model, which classifies cell death into four subclasses, according to their nuclear morphology (Fig. 2) . Apoptosis is defined by stage II chromatin condensation into compact figures, which are often globular or crescent shaped. Slightly different is apoptosis-like PCD, which is characterized by less-compact chromatin condensation, so-called stage I chromatin condensation. In contrast, in necrosis-like PCD no chromatin condensation is observed, but at best, chromatin clustering to loose speckles, whereas necrosis is characterized by cytoplasmatic swelling and cell membrane rupture (22).
Despite the numerous models proposed to categorize PCD, exclusive definitions are difficult to make and are probably artificial due to the overlap and shared signaling pathways between the different death programs. It has been shown that apoptotic and necrotic death markers can concomitantly be present in the same cell after cerebral ischemia, indicating that more than one death program may be activated at the same time (42). In addition, a cell may switch back and forth between different death pathways as shown in neuronal cell death that exhibited elements of autophagic degeneration upon oncogenic Ras expression, whereas it had characteristics of apoptotic cell death upon treatment with TNF-a (43). It has, therefore, been postulated that the dominant cell death phenotype is determined by the relative speed of the available death programs; although characteristics of several death pathways can be displayed, only the fastest and most effective death pathway is usually evident (44). In addition, attempts have been made to order caspase-independent cell death according to the cellular organelles involved (45). Organelles such as the mitochondria, lysosomes, or ER and plasma membrane death receptors can be involved in either of the subclasses but may play a more prominent role in certain types of PCD. As reviewed here and summarized in Fig. 3 
Organelles Involved In Programmed Cell Death
Mitochondria. Release of toxic proteins form the intermembrane space of the mitochondria triggered by permeabilization of the outer mitochondrial membrane constitutes the ''point of no return'' in most cases of PCD (Fig. 3) . Members of the Blc-2 family control this process tightly (46): upon apoptotic signals, proapoptotic Bcl-2 proteins such as Bax and Bak are activated, resulting in outer mitochondrial membrane permeabilization. In contrast, antiapoptotic Bcl-2 family members, such as Bcl-2 and Bcl-X L , can prevent this occurrence by heterodimerization with Bax-like proteins. Other proapoptotic Bcl-2 proteins which contain only the BH 3 domain (e.g., Bad, Bid, Bim, Bmf, and Noxa) act by opposing the inhibitory effect of Bcl-2 or Bcl-X L , or by activating Bax-like proteins by direct binding. A second mechanism of permeabilization of the outer mitochondrial membrane is the opening of a permeability transition pore in the inner mitochondrial membrane upon a variety of stimuli. This allows water and small molecules (up to 1.5 kDa) to pass through, leading to swelling of the intermembrane space and rupture of the outer mitochondrial membrane (reviewed by Green (46)).
The first protein shown to be released from the mitochondria upon apoptotic stimuli is cytochrome c, an essential component of the respiratory chain. Upon release in the cytoplasm, it forms, in the presence of ATP, the so-called ''apoptosome'' together with Apaf-1 and caspase 9. This triggers the classic apoptotic cascade, leading to apoptotic cell death. The catalytic function of cytochrome c is safeguarded by members of the inhibitor of apoptosis proteins family, which are in turn controlled by two other mitochondrial proteins, Smac/DIABLO and OMI/HtrA2 (Fig. 3) . In this way, OMI/HtrA2 plays a role in caspase-dependent cell death, but it can also act as an effector protein in necrosis-like PCD. This function is independent of its inhibitor of apoptosis proteins -binding activity but is done by its protease activity (47 -50). It is, however, difficult to make firm conclusions about to precise contribution of OMI/HtrA2 to cell death, as down-regulation of OMI/HtrA2 expression influences both its mitochondrial function and its cytosolic role in cell death (51). Another mitochondrial protein that potentially contributes to both caspase-independent and caspase-dependent cell death is endonuclease G. This protease is evolutionarily conserved with orthologues known in bacteria www.aacrjournals.org
Clin Cancer Res 2005;11(9) May 1, 2005 3157 Fig. 2 . Classification of cell death according to the nuclear morphology of the dying cell. Upon a lethal stimulus, a cell can die in different ways that can be classified according to their nuclear morphology. In apoptosis, there is chromatin condensation into compact figures, which are often globular or crescent shaped. Apoptotic morphology further includes shrinkage of the cell, membrane blebbing, and the formation of apoptotic bodies. Apoptosis is dependent of caspase 3 and caspase-activated DNAse. Apoptosis-like PCD is characterized by chromatin condensation that is less compact but which gives more complex and lumpy shapes and is caused by apoptosis inducing factor, endonuclease G, cathepsins, or other proteases. Any degree or combination with other apoptotic features can be found. In necrosis-like PCD, no chromatin condensation is observed, but at best, chromatin clustering to loose speckles, whereas necrosis is associated with cytoplasmic swelling and cell membrane rupture (Modified from Leist and Ja« a« ttela« (22)). Fig. 3 . Cross-talk between cellular organelles during cell death. Upon a lethal stimulus, a cell has access to different death programs that can be executed via caspases (apoptosis) or independent of caspases. Mitochondria, lysosomes and the ER can be involved in various pathways but may play a more prominent role in certain types of PCD. As depicted here, the signals from the different organelles are linked and may act both upstream and downstream of each other. It has therefore been postulated that the dominant cell death phenotype is determined by the relative speed of the available death programs, and only the fastest and most effective pathway is usually evident (44). For details see text. Note: for reasons of legibility, only the most important molecules and connections are included in this figure.
Caspase-Independent Cell Death
Cancer Research. Apoptosis inducing factor (AIF) is a mitochondrial protein that plays a pivotal role in PCD, as shown by Joza et al., who reported that targeted disruption of the AIF gene inhibited the first wave of programmed cell death during embryogenesis (54). AIF was first described by Susin et al. (55) and is normally retained in the intermembrane mitochondrial space, where it performs an oxidoreductase function (56). Similar to the bifunctional role of cytochrome c, AIF becomes an active cell killer when it is released to the cytosol; it then translocates to the nucleus and triggers, possibly together with endonuclease G (57), peripheral chromatin condensation and high molecular weight (50 kb) DNA loss (58-60). The lethal effects of AIF are controlled by the antiapoptotic protein heat shock protein 70 that interacts with AIF and protects against its apoptogenic effects (61).
Interestingly, the lysosomal protease cathepsin D has been reported to trigger AIF release independent of the caspasecascade (62), and AIF mediated cell death in Apaf 1 À/À and caspase 3
À/À cells (63). In addition, the presence of the broad caspase inhibitor zVAD-fmk did not prevent the mitochondrialnuclear translocation of AIF (64) nor did it prevent its lethal effects (58, 59), indicating that this protein is involved in caspase-independent, apoptosis-like PCD. This notion is supported by Yu et al., who showed that AIF release and subsequent cell death can be triggered independent of caspases by excessive calcium influx resulting in overactivation of poly (ADP-ribose) polymerase-1 (60). Furthermore, AIF and not caspase activation was shown largely responsible for pneumococcus-induced apoptosis in an experimental meningitis model (65), suggesting that caspase-independent cell death by AIF plays an important role in pathologic conditions. Others have, however, showed that mitochondrial release of AIF occurs downstream of cytochrome c in response to certain stimuli and may require caspase activation (66, 67). Apparently, AIF can serve as an additional response mechanism to facilitate the completion of caspase-dependent apoptosis in certain death paradigms, whereas it is capable of executing caspaseindependent cell death in other cell types (reviewed in ref. 68). Indeed, there is now accumulating evidence in vitro as well as in vivo suggesting that AIF can act as a safeguard death executioner in cancer cells with faulty caspase activation (69-71).
Lysosomes. In the classic apoptosis-necrosis paradigm, lysosomes were solely considered involved in necrotic and autophagic cell death, and the lysosomal proteases were believed to take care only of nonspecific protein degradation within the lysosome. In recent years, however, it has become evident that the role of lysosomes in cell death is far more sophisticated. One of the first studies reporting an active role for lysosomal proteases in cell death was based on the cloning of ''regression selected genes'' in rat prostate and mammary glands after hormone ablation. Increased amounts of the lysosomal enzyme cathepsin B were found in the basal aspect of cells in regressing tissue, indicating that cathepsin B is required for the local degradation of the basement membrane, which is one of the earliest morphologically recognizable events of active cell death (72) . Active participation of lysosomal proteases has since then been observed in cell death induced by several stimuli, including oxidative stress (73 -77) , TNF-a (16, 17, 78, 79) , bile salt-induced apoptosis (80, 81) , and chemotherapeutic drugs (15, 82) .
Studies with the synthetic lysosomotropic detergent MSDH indicate that the key factor in determining the type of cell death is the magnitude of lysosomal permeabilization and the amount of proteolytic enzymes released into the cytosol (83) . Whereas partial, selective permeabilization triggers apoptoticlike PCD, massive breakdown of lysosomes results in unregulated necrosis (reviewed in ref. 44). Several mechanisms to achieve the translocation of a balanced amount of lysosomal proteases to the cytoplasm, without risking a complete breakdown of the organelle and induction of necrotic cell death have been proposed. One theory involves accumulation of the lysosomotropic detergent sphingosine in the lysosomes, which could facilitate the release of lysosomal enzymes into the cytoplasm (18). Another possible mechanism is the generation of reactive oxygen species, which also can induce lysosomal leakage. Indeed, experimental evidence suggests that reactive oxygen species -induced lysosomal permeabilization usually precedes mitochondrial dysfunction (73, 74) , thereby creating a feedback loop in which mitochondrial-reactive oxygen species can lead to more lysosomal permeabilization (84) . An intriguing hypothesis is the translocation of proapoptotic members of the Bcl-2 family to the lysosomes, where they could induce the formation of pores and membrane permeabilization, similar to their well-known role in mitochondrial membrane polymerization (75 -77) . Recently, it has been described that heat shock protein 70, which antagonizes the apoptogenic effects of AIF, promotes cell survival by inhibiting lysosomal membrane permeabilization (85) .
The cysteine protease cathepsin B and L and the aspartatic protease cathepsin D are the most abundant lysosomal proteases. Cathepsin B and D are most stable at physiologic, cytoplasmatic pH and seem to have the most prominent role in apoptotic and necrotic like PCD (reviewed in ref. 86, 87) . Cathepsin B has been shown to translocate to the nucleus and thereby contribute to bile salt-induced apoptosis (81) . Indeed, cathepsin B can act as an effector protease, downstream of caspases in certain cell types (16, 88) , and is capable of executing cell death independent of the apoptotic machinery in WEHI-S fibrosarcoma and non -small cell lung cancer (NSCLC) cells (15, 16) . Other reports have, however, showed that lysosomal proteases rather promote cell death more indirectly by triggering mitochondrial dysfunction and subsequent release of mitochondrial proteins (14, 17, 82, 89, 90) . This may occur via the Bcl-2 family protein Bid (19, 91, 92), which is cleaved and translocated to the mitochondria after lysosomal disruption by lysosomotropic agents (93) . In addition, cathepsin D can trigger activation of Bax, leading to selective release of AIF from the mitochondria and PCD in T lymphocytes (62). Finally, lysosomal proteases have been reported to directly cleave and activate caspases, thereby confirming that lysosomal permeabilization often is an early event in the apoptotic cascade (94 -96) .
Taken together, it seems that lysosomal proteases trigger PCD not via a single specific pathway but rather via multiple pathways that may overlap with the traditional mediators of apoptosis (Fig. 3) . The molecular identity of the mediators and the necessity of activation of caspase-dependent pathways remain to be elucidated in many cases and may vary depending on the type of cells and the applied death stimulus (97) . Many other molecular pathways mediated by lysosomal enzymes are likely to be described in the near future.
Endoplasmic reticulum. The ER is an important sensor of cellular stress that can withhold protein synthesis and metabolism to restore cellular homeostasis (98) . If the damage to the ER is too extensive, this can initiate PCD via the unfolded protein response or via release of calcium into the cytoplasm (reviewed in ref. 99 ). This leads to activation of caspase 12, possibly via translocation of the Bcl-2 family member Bim to the ER (100). Caspase 12 in its inactive state is localized at the cytosolic face of the ER, but it triggers downstream caspases and apoptosis when it becomes activated (101, 102) . In addition and independent of caspase 12 activation, ER stress can induce permeabilization of the mitochondrial membrane and thus activate the classic apoptotic pathway as well as other mitochondrial death pathways (25, 103). Bcl-2 family proteins as well as cytoplasmatic calcium shifts orchestrate the cross talk between the mitochondria and the ER (104, 105) .
In addition, intracellular calcium influx caused by ER stress induces activation of a family of cytosolic proteases, the calpains (calcium-activated neutral proteases), which normally reside in the cytosol as inactive zymogens (106) . Calpains have been shown to act downstream of caspase activation and to contribute to the degradation phase of campthotecin-induced apoptosis in HL-60 cells (107, 108) . They are kept in control by their natural inhibitor calpastatin, which is in turn inactivated by calpain-or caspase-mediated cleavage (109) . In addition, Bax and likely also other yet undefined pathways are involved in the cross-talk between the calpain and caspase proteolytic system (110, 111) . Indeed, Sanvicens et al. have shown that both caspases and calpains contribute to oxidative stress-induced apoptosis in retinal photoreceptor cells (112) . Furthermore, a ''calpain-cathepsin cascade'' has been reported, in which activated calpains induce release of lysosomal cathepsins and subsequent cell death ( Fig. 3; refs. 113, 114) . Interestingly, vitamin D compounds have been reported to trigger cell death in MCF-7 cells executed by calpains in complete absence and independent of caspase activation (115 -117) , indicating that the ER may play a key role in certain types of caspaseindependent cell death (Fig. 3) . This notion is supported by several studies demonstrating an active and pivotal role for calpains in anthracycline-induced toxicity in cardiac myocytes (118) , neuronal (119, 120) , and pancreatic cell death (121) .
Death Stimuli Triggering Alternative Types of Programmed Cell Death
Caspase-dependent apoptosis plays a pivotal role in embryogenic development, but there is now accumulating evidence indicating that necrotic and apoptotic-like PCD are important safeguard mechanisms for the developing organism (122) . This is illustrated by knockout studies in caspase 3 or 9 À/À mice which show, despite an altered morphology and temporal delay in neuronal cell death, equal numbers of neurons that are ultimately lost during development. Moreover, certain neurologic areas such as the spinal cord and brainstem seem normal in both knockout and control animals, suggesting that the involvement of specific caspases and the occurrence of caspase-independent cell death may depend on the brain region, cell type, or the death stimulus (123) . Similar results were found in the early motoneuron death in the chick embryo cervical spinal cord, in which caspase activity was involved but for which it was not indispensable (124) . Many other physiologic cell deaths do not seem to occur through classic apoptosis but may primarily be executed by alternative proteases (122) . For instance, studies on maturation of osteoblasts in maturing bone (125) , differentiation of keratinocytes (126) (127) (128) , and differentiation of lens fiber cells (94, 129, 130) show that there is far more indirect than direct evidence that their death is apoptotic or caspase dependent.
Triggering of the TNF receptor-1 (TNFR-1) by TNF-a can lead to classic apoptosis via activation of the initiator protease caspase 8 in the death receptor pathway (131) . Other studies have raised the possibility that TNF-a may trigger apoptosis via an additional route, involving constituents of acidic vesicles that can generate ceramide as a second messenger (132, 133) . Indeed, cathepsin D has been found to mediate PCD in HeLa cells induced by TNF-a (134) . In addition, cathepsin B has been described to contribute to bile salt and TNF-a -induced hepatocyte apoptosis (17, 79, 81, 135) . The pivotal role of cathepsin B in hepatocyte apoptosis has further been shown in cathepsin B knockout mice, which were resistant to TNF-amediated apoptosis (78) . In addition, both genetic and pharmacologic inhibition of cathepsin B reduces hepatic inflammation and fibrogenesis upon bile duct ligation in mice (80) . Furthermore, it attenuates hepatocyte apoptosis and liver damage in steatotic mice livers after cold ischemia/warm reperfusion injury (136) . These results suggest that cathepsin B is indispensable for hepatocyte apoptosis induced by TNF-a or liver injury and implicate that cathepsin B inhibition may be of therapeutic interest in liver diseases (137) .
Successful treatment with chemotherapeutic drugs is largely dependent on their ability to trigger cell death in tumor cells and activation of apoptosis is at least partially involved in this process (138) . The majority of cytotoxic agents trigger the mitochondria pathway, but the death receptors have also been reported to be involved in chemotherapy-induced apoptosis (139, 140) . However, recent evidence suggests that there are forms of chemotherapy-induced cell death that cannot readily be classified as apoptosis or necrosis but fit more in the apoptosis-like/necrosis-like PCD model (22, 141, 142) . Table 1 gives an overview of caspase-independent cell death induced by chemotherapeutic agents. For instance, cell death induced by paclitaxel and the novel microtubule-interacting agents epothilone B and discodermolide in NSCLC cells was not prevented by the use of the broad-spectrum inhibitor zVAD-fmk nor was it reduced in Bcl-2 overexpressing or Fas-associated death domain-dominant negative cells, indicating that this class of agents primarily induces caspase-independent cell death in NSCLC cells (143, 144) . Interestingly, specific cathepsin B inhibitors, and not inhibitors of cathepsin D or calpains, did reduce the lethal effects of these drugs, thereby providing evidence for a cathepsin B -mediated cell death pathway induced by microtubule stabilizing agents (15) . Other studies in NSCLC cells suggest that the relative resistance to caspasedependent apoptosis that is frequently seen in this cell type can be circumvented by the triggering of an AIF-mediated, caspaseindependent mechanism (70) and AIF may determine the chemoresistance of NSCLC cells (145) . In addition, paclitaxel induced caspase-independent apoptosis via AIF in ovarian carcinoma cells (146) , indicating that the activation of a certain death pathway may vary upon the cellular system (97) . Although cell death in hematologic malignancies is more often mediated by the classic apoptotic proteases than in solid tumors (7, 141) , the occurrence of caspase-independent cell death has been reported in T lymphocytes and acute myeloid leukemia (147, 148) . Taken together, the cellular death response triggered by cytotoxic agents depends on the type and dose of chemotherapeutic stress within the cellular context and may involve classic apoptosis, as well as various types of apoptotic or necrotic PCD.
Conclusions
Despite the enormous importance of the discovery of apoptosis as a cell death program indispensable for embryogenesis and protection against unbridled cell growth, the apoptosis-necrosis paradigm is too simple to encompass the wide spectrum of possibilities we have to eliminate faulty and potentially harmful cells. Not only caspases, but also calpains, cathepsins, endonucleases, and other proteases can execute programmed cell death, and they can be directed by several cellular organelles, including mitochondria, lysosomes, and the ER, which can act independently, or collaborate with each other. Although several models of caspase-independent cell death have been described, the various death routes may overlap and several characteristics may be displayed at the same time. The evolutionary advantage of the existence of multiple death pathways is obvious: it protects the organism against the development of malignant diseases as many burdens have to be overcome before a cell becomes a tumor cell. This may explain the relative rarity of cancer, in respect to the huge number of cell divisions and mutations during a human life. The growing knowledge of caspase-independent cell death pathways is important for the oncology field, as they could potentially be manipulated to develop new cancer therapies. 
